Renal carcinogenesis: Genotype, phenotype and dramatype

Cancer Science

Volumn 94, Issue 2, 2003, Pages 142-147

  Hino, Okio ^a   Kobayashi, Toshiyuki ^a   Momose, Shuji ^a   Kikuchi, Yasushi ^a   Adachi, Hiroyuki ^a   Okimoto, Kazuo ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL SPECIFICITY; ENVIRONMENTAL FACTOR; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENOTYPE; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RAT STRAIN; RETROSPECTIVE STUDY; REVIEW; SPECIES DIFFERENCE; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; GENES, DOMINANT; GENOTYPE; HUMANS; INTERFERON TYPE II; KIDNEY NEOPLASMS; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASTIC SYNDROMES, HEREDITARY; PHENOTYPE; PROTEINS; RATS; RATS, MUTANT STRAINS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0038662963     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01410.x     Document Type: Review

References (59)

1. Eker R, Mossige J. A dominant gene for renal adenomas in the rats. Nature 1961; 189: 858-9.
2. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
3. Hino O, Testa J, Buetow K, Taguch T, Zhou JY, Bremer M, Bruzel A, Yeung R, Levan G, Knudson AG, Tartof KD. Universal mapping probes and origin of human chromsome 3. Proc Natl Acad Sci USA 1993; 90: 730-4.
4. Yeung RS, Buetow KH, Testa JR, Knudson AG. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci USA 1993; 90: 8038-42.
5. Hino O, Mitani H, Nishizawa M, Katsuyama H, Kobayashi E, Hirayama Y. A novel renal cell carcinoma susceptibility gene maps on chromosome 10 in the Eker rat. Jpn J Cancer Res 1993; 84: 1106-9.
6. Hino O, Mitani H, Knudson AG. Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res 1993; 53: 5856-8.
7. Hino O, Kobayashi T, Tsuchiya H, Kikuchi Y, Kobayashi E, Mitani H, Hirayama Y. The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (Tsc2) gene. Biochem Biophys phys Res Commun 1994; 203: 1302-8.
8. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 1995; 9: 70-4.
9. Yeung RC, Xiao GH, Jin F, Lee W-C, Testa JR, Knudson AG. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 1994; 91: 11413-6.
10. Kobayashi T, Mitani H, Takahashi R, Hirabayashi M, Ueda M, Tamura H, Hino O. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci USA 1997; 94: 3990-3.
11. Hino O, Klein-Szanto AJP, Freed JJ, Testa JR, Brown DQ, Vilensky M, Yeung RS, Tartof KID, Knudson AG. Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci USA 1993; 90: 327-31.
12. Everitt JI, Goldsworthy TL, Wolf DS, Walker CL. Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome. J Urol 1992; 148: 1932-6.
13. Hino O, Mitani H, Katsuyama H, Kubo Y. A novel cancer predispostion syndrome in the Eker rat model. Cancer Lett 1994; 83: 117-21.
14. Kubo Y, Mitani H, Hino O. Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in Eker rat. Cancer Res 1994; 54: 2633-5.
15. Kubo, Y, Kikuchi Y, Mitani H, Kobayashi E, Kobayashi T, Hino O. Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model. Jpn J Cancer Res 1995; 86: 828-32.
16. Hino O, Kobayashi T, Mitani H, Kubo H, Tsuchiya Y, Kikuchi Y, Nishizawa M, Hirayama Y. The Eker rat, a model of dominantly inherited cancer syndrome. Transplant Proc 1995; 27: 1529-31.
17. Yeung RS, Katsetos CD, Klein-Szanto A. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 1997; 151: 1477-86.
18. Mizuguchi M, Takahashi S, Yamanouchi H, Nakazato Y, Mitani H, Hino O. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma. J. Neuropathol Exp Neural 2000; 59: 188-96.
19. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T. Renal carcino-genesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 1999; 59: 1206-11.
20. Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, Noda T, Hino O. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA 2001; 98: 8762-7.
21. Kobayashi T, Urakami S, Hirayama Y, Yamamoto T, Nishizawa M, Takahara T, Kubo Y, Hino O. Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn J Cancer Res 1997; 88: 254-61.
22. Hino O, Mitani H, Sakurai J. "Second hit" of Tsc2 gene in radiation induced renal tumors of Eker rat model. Int Congr Ser 2002; 1236: 163-74.
23. Kobayashi T, Nishizawa M, Hirayama Y, Kobayashi E, Hino O. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. Nucleic Acids Res 1995; 23: 2608-13.
24. Kobayashi T, Urakami S, Cheadle JP, Aspinwall R, Harris P, Sampson JR, Hino O. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homologue. Mamm Genome 1997; 8: 554-8.
25. Orimoto K, Tsuchiya H, Kobayashi T, Matsuda T, Hino O. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. Biochem Biophys Res Commun 1996; 219: 70-5.
26. Jin F, Wienecke R, Xiao GH, Maize JC Jr, DeClue JE, Yeung RS. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci USA 1996; 93: 9154-9.
27. van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van der Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P. Interaction between hamartin and tuberin, the TSC1 and TSC2 products. Hum Mol Genet 1998; 7: 1053-7.
28. Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJJ, Sampson JR, Wienecke R, DeClue JE. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 gene product tuberin by inhibiting its ubiquitination. Oncogene 2000; 19: 6306-16.
29. Momose S, Kobayashi T, Mitani H, Hirabayashi M, Ito K, Ueda M, Nabeshima Y, Hino O. Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. Hum Mol Genet 2002; 11: 2997-3006.
30. Nellist M, Verhaaf B, Goedbloed MA, Reuser AJJ, van der Ouweland AMW, Halley DJJ. TSC2 missense mutations inhibit tuberin hosphorylation and prevent formation of the tuberin-hamartin complex. Hum Mol Genet 2001; 10: 2889-98.
31. Gao X, Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 2001; 15: 1383-92.
32. Ito N, Rubin GM. gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 1999; 96: 529-39.
33. Stocker H, Hafen E. Genetic control of cell size. Curr Opin Genet Dev 2000; 10: 529-35.
34. Fukuda T, Mitani H, Tsutsumi M, Konishi Y, Hino O. Specific induction of hepatocellular adenomas by transplacental administration of ENU in the Tsc2 gene mutant (Eker) rat. Int J Oncol 1998; 13: 957-61.
35. Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D. Tsc tumor suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002; 4: 699-704.
36. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2: 760-8.
37. Nellist M, Goedbloed MA, de Winter C, Verhaaf B, Jankie A, Reuser AJJ, van den Ouweland AMW, van der Sluijs P, Halley DJJ. Identification and characterization of the interaction between tuberin and 14-3-3 z. J Biol Chem 2002; 277: 39417-24.
38. Tsuchiya H, Orimoto K, Kobayashi T, Hino O. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res 1996; 56: 429-33.
39. Kubo Y, Klimek F, Kikuchi Y, Bannasch P, Hino O. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure. Cancer Res 1995; 55: 989-90.
40. Hino O, Majima S, Kobayashi T, Honda S, Momose S, Kikuchi Y, Mitani H. Multistep renal carcinogenesis as gene expression disease in tumor suppressor TSC2 gene mutant model-genotype, phenotype and environment. Mutat Res 2001; 477: 155-64.
41. Tsuchiya H, Tsuchiya Y, Kobayashi T, Kikuchi Y, Hino O. Isolation of genes differentially expressed between the Yoshida sarcoma and Long-survival Yoshida sarcoma variants: origin of Yoshida sarcoma revisited. Jpn J Cancer Res 1994; 85: 1099-104.
42. Hino O, Kobayashi E, Nishizawa M, Kubo Y, Kobayashi T, Hirayama Y, Takai S, Kikuchi Y, Tsuchiya H, Orimoto K, Kajino K, Takahara T, Mitani H. Renal carcinogenesis in the Eker rat. J Cancer Res Clin Oncol 1995; 121: 602-5.
43. Urakami S, Tsuchiya H, Orimoto K, Kobayashi T, Igawa M, Hino, O. Overexpression of members of the AP-1 transcriptional factor fan-lily from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun 1997; 241: 24-30.
44. Yamashita Y, Yokoyama M, Kobayashi E, Takai S, Hino O. Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun 2000; 75: 134-40.
45. Majima S, Kajino K, Fukuda T, Otsuka F, Hino O. A novel gene "Niban" up-regulated in renal carcinogenesis: cloning by the cDNA-amplified fragment length polymorphism approach. Jpn J Cancer Res 2000; 91: 869-74.
46. Hino O, Kobayashi E, Hirayama Y, Kobayashi T, Kubo Y, Tsuchiya H, Kikuchi Y, Mitani H. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mal Carcinog 1995; 14: 23-27.
47. Fukuda T, Hirayama Y, Mitani H, Maeda H, Tsutsumi M, Konishi Y, Hino O. Generation of metastatic variants of Eker renal carcinoma cell lines for experimental investigation of renal cancer metastasis. Jpn J Cancer Res 1998; 89: 1104-8.
48. Urakami S, Tokuzen R, Tsuda H, Igawa M, Hino O. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J Urol 1997; 158: 275-8.
49. Satake N, Urakami S, Hirayama Y, Izumi K, Hino O. Biallelic mutations of the Tsc2 gene in chemically induced rat renal carcinoma. Int J Cancer 1998; 77: 895-900.
50. Satake N, Kobayashi T, Kobayashi E, Izumi K, Hino O. Isolation and characterization of a rat homologue of the human tuberous sclerosis 1 gene (Tsc1) and analysis of its mutations in rat. Cancer Res 1999; 59: 849-55.
51. Kajino K, Yakurai J, Hirayama Y, Takahara T, Fukui I, Ishikawa Y, Hino O. LOH of tumor suppressor TSC2 gene locus in human renal cell carcinomas and lung carcinomas. Proc Jpn Cancer Assoc 1997: 279.
52. Miki S, Miki Y, Mitani H, Sato B, Yamamoto M, Hino O. Hyperlipidemia enhancement of renal preneoplasia but not tumor formation is due to elevated apoptosis in the Eker rat. Cancer Res 1997; 57: 4673-6.
53. Hino O, Kobayashi T, Mitani H. Prevention of hereditary carcinogenesis. Proc Japan Acad 2002; 78B: 31-3.
54. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K. Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 1994; 91: 614-8.
55. Okamoto T, Furuya M, Yamakawa T, Yamamura K, Hino O. TNF-alpha gene expression in the liver of the IFN-ganuna transgenic mouse with chronic active hepatitis. Biochem Biophys Res Commun 1996; 226: 762-8.
56. Akbar SMF, Kajino K, Tanimoto K, Yamamura K, Onji M, Hino O. Unique features of dendritic cells in IFN-γ transgenic mice: relevance to cancer development and therapeutic implications. Biochem Biophys Res Commun 1999; 259: 294-9.
57. Okimoto K, Kouchi M, Kikawa E, Toyosawa K, Koujitani T, Tanaka K, Matsuoka N, Sakurai J, Hino O. A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma. Jpn J Cancer Res 2000; 91: 1096-9.
58. Hino O, Okimoto K, Kouchi M, Sakurai J. A novel renal carcinoma predisposing gene of the Nihon rat maps on chromosome 10. Jpn J Cancer Res 2001; 92: 1147-9.
59. Kobayashi T, Adachi H, Mitani H, Hirayama Y, Hino O. Toward chemotherapy for Tsc2-mutant renal tumor. Proc Japan Acad 2003; 79B: 22-5.